Data / Form D filings / GENELUX Corp
GENELUX Corp: Form D filings
GENELUX Corp, a biotechnology company in Westlake Village, CA, filed 5 Form D notices with the SEC between 2009 and 2023. The latest, on June 29, 2023, reports $5.5 million sold of a $18 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2625 TOWNSGATE ROAD, SUITE 230, Westlake Village, CA, 91361
- Phone
- (805) 267-9889
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1231457
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2023 | New notice | $18,000,000 | $5,500,000 | $12,500,000 | 19 | Jun 20, 2023 | sec.gov |
| Jun 15, 2023 | New notice | $33,304,319 | $18,304,319 | $15,000,000 | 69 | May 31, 2023 | sec.gov |
| Jun 6, 2012 | New notice | $48,000,000 | $481,268 | $47,518,732 | 8 | Apr 24, 2012 | sec.gov |
| Jul 9, 2010 | New notice | $25,000,000 | $80,000 | $24,920,000 | 3 | Jun 24, 2010 | sec.gov |
| Apr 9, 2009 | New notice | $25,000,000 | $48,000 | $24,952,000 | 1 | Mar 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mary Mirabelli | Director | |
| Thomas Zindrick | Executive Officer, Director | |
| Doug Samuelson | Executive Officer | |
| Gabe Woodward | Director | |
| Paul Scigalla | Executive Officer | |
| James Tyree | Director | |
| John Thomas | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 26, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GENELUX Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.